Prostate cancer is one of the most life-threatening disorders that occur in males. It has now
become the third most common disease all over the world, and emerging cases and spiking …

Background New biomarkers of progression in patients with prostate cancer (PCa) are
needed to improve their classification and clinical management. This systematic review …

Prostate cancer is a malignant tumor originating from the prostate gland, significantly
affecting patients' quality of life and survival rates. Public data was utilized to identify …

Introduction: Prostate cancer is the most frequently diagnosed male malignancy and the fifth
leading cause of cancer death in men worldwide. Since the advent of screening methods …

Understanding the intricate relationship between an individual's genetic variants
(genotypes) and their observable traits (phenotypes) is imperative for comprehending the …

Introduction: Prostate cancer is the most frequently diagnosed male malignancy and the fifth
leading cause of cancer death in men worldwide. Since the advent of screening methods …

Le cancer de la prostate est l'un des cancers les plus fréquents chez les hommes. Le rôle de
l'obésité dans son étiologie revêt un intérêt grandissant. Les associations observées sont …

Le carcinome intracanalaire de la prostate (intraductal carcinoma of the prostate, IDC-P) est
un variant histologique agressif du cancer de la prostate retrouvé dans environ 20% des …

El cáncer de próstata (CaP) es el tumor no cutáneo más frecuente y el segundo tumor con
mayor mortalidad en varones. Las Guías Clínicas Europeas (GCE) recomiendan para el …

The study focuses on CD103+ CD8+ tissue-resident memory T cells (TRMs) in prostate
cancer (PCa), aiming to understand their impact on tumor progression and patient …